Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Peer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluation.

Tikellis G, Lee JYT, Corte TJ, Maloney J, Bartlett M, Crawford T, Glaspole IN, Goh N, Herrmann K, Hey-Cunningham AJ, Keir G, Khor YH, Price J, Sandford DG, Spencer L, Teoh A, Walsh J, Webster S, Holland AE.

Respirology. 2020 Mar 23. doi: 10.1111/resp.13807. [Epub ahead of print]

PMID:
32207225
2.

Ambulatory oxygen in fibrotic ILD: a pilot, randomised, triple-blinded, sham-controlled trial.

Khor YH, Holland AE, Goh NS, Miller BR, Vlahos R, Bozinovski S, Lahham A, Glaspole I, McDonald CF.

Chest. 2020 Feb 27. pii: S0012-3692(20)30343-3. doi: 10.1016/j.chest.2020.01.049. [Epub ahead of print]

PMID:
32113924
3.

Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns.

Khor YH, Renzoni EA, Visca D, McDonald CF, Goh NSL.

ERJ Open Res. 2019 Sep 16;5(3). pii: 00118-2019. doi: 10.1183/23120541.00118-2019. eCollection 2019 Jul. Review.

4.

Therapeutic burden in interstitial lung disease: Lessons to learn.

Khor YH, Glaspole I, Goh NSL.

Respirology. 2019 Jun;24(6):566-571. doi: 10.1111/resp.13480. Epub 2019 Feb 20.

5.

Post-Hospitalization Short-Term Oxygen Therapy: Use of a Clinical Management Pathway and Long-Term Follow-Up.

Khor YH, Wong R, McDonald CF.

Respir Care. 2019 Mar;64(3):272-278. doi: 10.4187/respcare.06303. Epub 2018 Nov 6.

6.

Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Eapen MS, Hansbro PM, Larsson-Callerfelt AK, Jolly MK, Myers S, Sharma P, Jones B, Rahman MA, Markos J, Chia C, Larby J, Haug G, Hardikar A, Weber HC, Mabeza G, Cavalheri V, Khor YH, McDonald CF, Sohal SS.

Drugs. 2018 Nov;78(16):1717-1740. doi: 10.1007/s40265-018-1001-8. Review.

PMID:
30392114
7.

Exertional Desaturation and Prescription of Ambulatory Oxygen Therapy in Interstitial Lung Disease.

Khor YH, Goh NS, Glaspole I, Holland AE, McDonald CF.

Respir Care. 2019 Mar;64(3):299-306. doi: 10.4187/respcare.06334. Epub 2018 Oct 30.

8.

The clinical, biochemical, and ultrasonographic characteristics of patients with hidradenitis suppurativa in Northern Peninsular Malaysia: a multicenter study.

Loo CH, Tan WC, Tang JJ, Khor YH, Manikam MT, Low DE, Chan KH, Chan KH, Teoh YM, Sohot NQA, Tang MM, Chan LC.

Int J Dermatol. 2018 Dec;57(12):1454-1463. doi: 10.1111/ijd.14210. Epub 2018 Sep 4.

PMID:
30182482
9.
10.

Oxygen Therapy for Interstitial Lung Disease: Physicians' Perceptions and Experiences.

Khor YH, Goh NSL, McDonald CF, Holland AE.

Ann Am Thorac Soc. 2017 Dec;14(12):1772-1778. doi: 10.1513/AnnalsATS.201705-372OC.

PMID:
28796538
11.

Portable oxygen concentrators versus oxygen cylinder during walking in interstitial lung disease: A randomized crossover trial.

Khor YH, McDonald CF, Hazard A, Symons K, Westall G, Glaspole I, Goh NSL, Holland AE.

Respirology. 2017 Nov;22(8):1598-1603. doi: 10.1111/resp.13083. Epub 2017 May 23.

PMID:
28544460
12.

Oxygen Therapy for Interstitial Lung Disease. A Mismatch between Patient Expectations and Experiences.

Khor YH, Goh NSL, McDonald CF, Holland AE.

Ann Am Thorac Soc. 2017 Jun;14(6):888-895. doi: 10.1513/AnnalsATS.201611-934OC.

PMID:
28267349
13.

Patients' estimates of their sleep times: reliability and impact on diagnosis of obstructive sleep apnoea.

Khor YH, Tolson J, Churchward T, Rochford P, Worsnop C.

Intern Med J. 2015 Aug;45(8):850-3. doi: 10.1111/imj.12798.

PMID:
25944502
14.

Successful pregnancy in ventilatory failure due to campomelic dysplasia with severe kyphoscoliosis.

Khor YH, Walker S, Rautela L, Chao C, Robinson A, Howard M.

Intern Med J. 2014 Jul;44(7):712-3. doi: 10.1111/imj.12472. No abstract available.

PMID:
25041778
15.
16.

Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis.

Steinfort DP, Khor YH, Manser RL, Irving LB.

Eur Respir J. 2011 Apr;37(4):902-10. doi: 10.1183/09031936.00075310. Epub 2010 Aug 6. Review.

17.

A 69-year-old smoker with mediastinal and hilar lymphadenopathy.

Khor YH, Steinfort DP, Buchanan MR, Gunawardana D, Antippa P, Irving LB.

Thorax. 2010 Feb;65(2):132-8, 187. doi: 10.1136/thx.2009.123828. No abstract available.

PMID:
20147591
18.

Increased vascular permeability precedes cellular inflammation as asthma control deteriorates.

Khor YH, Teoh AK, Lam SM, Mo DC, Weston S, Reid DW, Walters EH.

Clin Exp Allergy. 2009 Nov;39(11):1659-67. doi: 10.1111/j.1365-2222.2009.03349.x.

PMID:
19860817
19.

Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction.

Khor YH, Feltis BN, Reid DW, Ward C, Johns DP, Wood-Baker R, Walters EH.

Clin Exp Allergy. 2007 Aug;37(8):1189-98.

PMID:
17651149

Supplemental Content

Support Center